Research on Acetyl L-Carnitine shows it can be very useful in supporting normal brain function, and possibly be useful for strokes, Down's syndrome and the management of various neuropathies
Some trials in overweight individuals with type 1 diabetes report up to a 13.3 percent reduction in body weight when taking the SGLT-2 inhibitor empagliflozin
Multivariate analysis for recurrent and first episode subjects showed only C3, C4, and C16 were higher in the recurrent schizophrenia group at baseline
[1] [3] Humans synthesize carnitine from the substrate TML (6- N -trimethyllysine), which is in turn derived from the methylation of the amino acid lysine
Sisley S, Gutierrez-Aguilar R, Scott M, D'Alessio DA, Sandoval DA, Seeley RJ